Highnoon Laboratories Limited (PSX: HINOON) has announced that its Board of Directors has approved, in principle, a potential acquisition, according to a filing submitted to the Pakistan Stock Exchange on Monday.
The decision was taken during the board meeting held on February 2, 2026.
The company said the proposed acquisition is aimed at strengthening its strategic position through a possible expansion of its business footprint, enhancement of its product portfolio, and the realization of operational and commercial synergies, including wider market access and improved distribution efficiencies.
Highnoon Laboratories clarified that the proposed transaction is currently at an evaluation stage and is subject to due diligence, negotiations, and the execution of definitive agreements. The acquisition will also require the necessary corporate and regulatory approvals, along with the fulfillment of other customary conditions.
The company said it will make further disclosures in accordance with applicable laws and the PSX Rule Book as developments occur.